Kuhn & Co Investment Counsel’s CME Group CME Stock Holding History

Kuhn & Co Investment Counsel’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-865	Closed	-$255K	–	150
2026 Q1	$255K	Buy	865 +4	+0.5%	+$1.19K	0.16%	119
2025 Q4	$235K	Buy	+861	New	+$234K	0.16%	130

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Kuhn & Co Investment Counsel's CME Position: Q2 2026 in Review

Kuhn & Co Investment Counsel sold out of CME Group (CME) in Q2 2026, closing a stake of 865 shares — an estimated $255K sold.

Kuhn & Co Investment Counsel first reported a position in CME in Q4 2025 and held it in 2 quarters. The position peaked at $255K in Q1 2026. 1,704 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Kuhn & Co Investment Counsel reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Kuhn & Co Investment Counsel sold 865 CME Group shares in Q2 2026, an estimated $255K.
Kuhn & Co Investment Counsel first reported a position in CME Group in Q4 2025 and held it in 2 quarters.
Kuhn & Co Investment Counsel's CME Group position peaked at $255K in Q1 2026.
1,704 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Kuhn & Co Investment Counsel's 13F filing for Q2 2026, filed 31 Jul 2026.